EXALTA Group — preferred equity, alongside Montagu

Kinnerton Hill is pleased to announce a bespoke preferred equity investment in EXALTA Group, the global Medtech contract development and manufacturing organisation formed through the strategic merger of three Montagu-owned businesses. The transaction supports the next phase of EXALTA's growth across high-growth surgical end-markets, sitting alongside Montagu's continued majority ownership of the platform.

EXALTA represents a distinctive proposition in the Medtech CDMO landscape: unique scale combined with genuine depth of technical capability and a meaningful intellectual property base in surgical applications. The merger of three established Montagu portfolio businesses into a single platform creates a partner of choice for surgical OEMs navigating an increasingly complex regulatory, technological and commercial environment. Kinnerton Hill's capital was structured to provide the company with the financial flexibility to capitalise on that positioning without disrupting the operating cadence the management team has built.